⚡ StockFin Pro 100-stock AI Radar. No daily limits. No ads. View Plans →

Godavari Drugs Ltd (530317) — Board Meeting | 31 August 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings
📢 Key Event
Board approved alteration of memorandum to add nutraceuticals and dietary supplements as a new business line, requiring shareholder approval at the 38th AGM.
🔄 What Changed
Added nutraceuticals and dietary supplements to main objects clause; requires special resolution approval at 38th AGM; revised meeting notice set for 25 September 2026.
🔮 What's Next
The amendment will take effect upon shareholder approval at the 38th AGM on 25 September 2026 and upon filing Form MGT-14 with the Registrar of Companies.
💡 Investor Takeaway
Shareholders must approve the new business line, which expands operations beyond pharmaceuticals into nutraceuticals and dietary supplements.

Godavari Drugs approved altering its memorandum to add nutraceuticals and dietary supplements as a new business line, requiring shareholder approval at the 38th AGM on 25 September 2026, and set a revised meeting notice for that date.

📄 View Original Announcement (PDF)

⚡ StockFin Pro 100-stock AI Radar. No daily limits. No ads. View Plans →
📊 Stock Analysis — 530317 ✨ Ask AI About This

About Godavari Drugs Ltd (530317)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹99.25 Cr P/E: 19.0 ROE: 9.6% ROCE: 8.4%

View full 530317 stock details →

📡 Get AI alerts when 530317 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 530317 — Free

💡 Ask AI about this filing

Ask AI Free →

📊 More 530317 filings

No other filings yet.

🔥 Also filed on 31 August 2026

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day

⚡ StockFin Pro Go Pro — bigger Radar, no daily limits Upgrade

© 2026 StockFin.ai — AI-powered Indian stock research

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd